- FOUNDED 2021
Overview
The COSA Global Oncology Group was established in response to rising cancer incidence globally with 70% of new diagnoses expected to occur in low and middle income countries (LMICs), with a corresponding need for access to cancer prevention, screening, diagnosis and treatment.
This Group aims to promote global oncology in the Asia Pacific region with stakeholders in Australia and New Zealand through these themes:
Education
- Increase educational partnerships within the APAC region through in-country training, twinning partnerships and observerships
- Engage and train ANZ clinicians in global oncology
Research
- Increase research capacity in LMICs through regional collaboration
- Promote high quality research in global oncology within ANZ
Advocacy
- Leverage funding from professional institutions, government, industry, not-for-profit organisations and hospitals
- Engage members in global cancer policy and advocacy
Collaboration
- Support and promote institutional collaborations between ANZ and APAC LMICs through partnerships between clinical and research institutions
- Foster collaboration in global cancer care among COSA members
- Collaboration in grant applications for global oncology projects
- Working with international partners who have members active in this area
Group information
[Chair] Prof Desmond Yip, The Canberra Hospital, ACT
[Deputy Chair] Dr Milita Zaheed, Prince of Wales Hospital, NSW
Dr Madhavi Chilkuri, Ballarat Austin Radiation Oncology Centre, VIC
Prof Christos Karapetis, Flinders Medical Centre, SA
Ms Karen Lanyon, Consumer
Prof Sankha Mitra, Kalgoorlie Health, WA
Dr Brooke Wilson, Queen’s University, Kingston, Canada
Dr Ganes Pranavan, The Canberra Hospital, ACT
Mrs Marissa Ryan, Princess Alexandra Hospital, QLD
Dr Mei Ling Yap, Liverpool and Macarthur Cancer Therapy Centres, NSW
What’s the latest
Group Chair

Group Chair
Desmond Yip
Global Oncology Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 9 hours ago
RT by @COSAoncology: We can't thank enough all those who helped our team locally: @HNEHealth @UON_research Calvary Mater Newcastle, all our…
Read More >
COSAoncology 10 hours ago
RT by @COSAoncology: Data from recent #cancersurvivorship symposium. We need tools (https://t.co/9CokjAtani) to extend basic psychological c…
Read More >
COSAoncology 3 days ago
RT by @COSAoncology: 🚨1 week left🚨 to submit your expressions of interest to join the @COSAoncology Survivorship Executive Committee. EOI’s…
Read More >
COSAoncology 4 days ago
RT by @COSAoncology: Dr Robyn Brennen’s Clinical Oncology Society of Australia (COSA) poster #2: Adjuvant therapy was associated with increase…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Such an important area of research and applies all over the world. Huge disparities for Australia's First Peoples as wel…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Great opportunity to make a difference in the lives of people with Head & Neck Cancer. #HNCSM #PHD @hncanceraus @Sydney_Uni @Us…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: .@Sabesan68 @profevasegelov @jrzalcberg @COSAoncology @VCCCAlliance @RtnVic @awrccentre @MOGA_ORG #dct
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Hybrid #decentralized #clinicaltrials and #telehealth to improve patient access to trials are coming 💊 Site, sponsor and r…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Our @COSAoncology Survivorship Executive Committee is seeking expressions of interest for new members. If you’re a COSA…
Read More >